# Apodex 1.1 vs Claude Opus 4.7 (Adaptive)

> Side-by-side benchmark comparison for Apodex 1.1 and Claude Opus 4.7 (Adaptive) across agentic, coding, multimodal, knowledge, reasoning, multilingual, and math tasks.

- Canonical page: https://benchlm.ai/compare/apodex-1-1-vs-claude-opus-4-7-adaptive
- Last updated: October 9, 2026

- Shared sourced benchmarks: 2
- HTML indexing: indexable
- Ranking lane: BenchAlign v5.8

## Quick Verdict

Evidence is too thin for a benchmark verdict: Apodex 1.1 and Claude Opus 4.7 (Adaptive) share only 2 sourced benchmark rows.

## Summary

- Only 2 shared sourced benchmark rows are available. That is not enough for a broad capability verdict, so this mirror does not name an overall winner.
- Apodex 1.1 has the lower published output-token price.
- Claude Opus 4.7 (Adaptive) has the larger published context window at 1M.

## Model Snapshot

| Property | Apodex 1.1 | Claude Opus 4.7 (Adaptive) |
|----------|----------|----------|
| Creator | Apodex | Anthropic |
| Type | Proprietary | Proprietary |
| Reasoning | Reasoning | Reasoning |
| Context | N/A | 1M |
| Independent public score (not head-to-head) | 50.64 | 67.91 |
| Benchmarks Covered | 10 | 21 |
| Pricing (input/output) | Pricing unavailable / Pricing unavailable | $5.00 / $25.00 |

## Category Breakdown

### Agentic

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 45.4 (Estimated · #52/122)
- Claude Opus 4.7 (Adaptive) public-lane score: 59.8 (Supported · #23/122)

| Benchmark | Apodex 1.1 | Claude Opus 4.7 (Adaptive) | Winner |
|-----------|-----------|-----------|--------|
| Terminal-Bench 2.1 | 70.8% | Coming soon | Coming soon |
| HLE w/ tools | 56.1% | Coming soon | Coming soon |
| APEX-Agents | 38.5% | Coming soon | Coming soon |
| DeepSearchQA | 92.4% | Coming soon | Coming soon |
| Terminal-Bench 2.0 | Coming soon | 69.4% | Coming soon |
| BrowseComp | Coming soon | 79.3% | Coming soon |
| MCP Atlas | Coming soon | 77.3% | Coming soon |
| OSWorld-Verified | Coming soon | 78% | Coming soon |
| CyberGym | Coming soon | 73.1% | Coming soon |
| OSWorld 2.0 | Coming soon | 18.2% | Coming soon |
| JobBench | Coming soon | 45.9% | Coming soon |

### Coding

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 42.7 (Estimated · #59/146)
- Claude Opus 4.7 (Adaptive) public-lane score: 56.2 (Estimated · #28/146)

| Benchmark | Apodex 1.1 | Claude Opus 4.7 (Adaptive) | Winner |
|-----------|-----------|-----------|--------|
| Terminal-Bench 2.1 | 70.8% | Coming soon | Coming soon |
| SWE-bench Verified | 77.7% | 87.6% | Claude Opus 4.7 (Adaptive) |
| SWE-bench Pro | Coming soon | 64.3% | Coming soon |
| Terminal-Bench 2.0 | Coming soon | 69.4% | Coming soon |

### Reasoning

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 76.8 (Unranked · 2 rankable rows)
- Claude Opus 4.7 (Adaptive) public-lane score: 53.6 (Unranked · 3 rankable rows)

| Benchmark | Apodex 1.1 | Claude Opus 4.7 (Adaptive) | Winner |
|-----------|-----------|-----------|--------|
| MRCR v2 128K-256K | Coming soon | 59.2% | Coming soon |
| ARC-AGI-2 | Coming soon | 75.8% | Coming soon |
| ARC-AGI-3 | Coming soon | 0.2% | Coming soon |

### Multimodal & Grounded

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 77.7 (Unranked · 1 rankable row)
- Claude Opus 4.7 (Adaptive) public-lane score: 50.1 (#38/49)

| Benchmark | Apodex 1.1 | Claude Opus 4.7 (Adaptive) | Winner |
|-----------|-----------|-----------|--------|
| OfficeQA Pro | Coming soon | 43.6% | Coming soon |
| CharXiv | Coming soon | 91% | Coming soon |
| CharXiv w/o tools | Coming soon | 82.1% | Coming soon |

### Knowledge

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 53.5 (Supported · #59/174)
- Claude Opus 4.7 (Adaptive) public-lane score: 64 (Estimated · #31/174)

| Benchmark | Apodex 1.1 | Claude Opus 4.7 (Adaptive) | Winner |
|-----------|-----------|-----------|--------|
| HLE | 56.1% | 54.7% | Apodex 1.1 |
| FrontierScience Research | 63.3% | Coming soon | Coming soon |
| BioMysteryBench (human-difficult) | 35.3% | Coming soon | Coming soon |
| GPQA | Coming soon | 94.2% | Coming soon |
| GPQA-D | Coming soon | 94.2% | Coming soon |
| HLE w/o tools | Coming soon | 46.9% | Coming soon |

### Mathematics

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: Coming soon
- Claude Opus 4.7 (Adaptive) public-lane score: Coming soon

| Benchmark | Apodex 1.1 | Claude Opus 4.7 (Adaptive) | Winner |
|-----------|-----------|-----------|--------|
| IMO 2026 | 31/42 | Coming soon | Coming soon |
| FrontierMath (legacy) | Coming soon | 43.8% | Coming soon |

## FAQ

### Is there enough evidence to pick between Apodex 1.1 and Claude Opus 4.7 (Adaptive)?

Not yet. The models share only 2 sourced benchmark rows, so this mirror reports the available measurements and metadata without naming a broad winner.

### What can I compare safely on this page?

Published pricing, context windows, model type, and individual shared benchmark rows are directly comparable. Independent overall scores and non-overlapping benchmark coverage are labeled separately and should not be read as a controlled head-to-head result.

## Related Comparisons

- [Apodex 1.1 vs Apodex 1.1 Mini](/compare/apodex-1-1-vs-apodex-1-1-mini)
- [Claude Opus 4.7 (Adaptive) vs Apodex 1.1 Mini](/compare/apodex-1-1-mini-vs-claude-opus-4-7-adaptive)
- [Apodex 1.1 vs Claude Opus 4.7](/compare/apodex-1-1-vs-claude-opus-4-7)
- [Claude Opus 4.7 (Adaptive) vs Claude Opus 4.7](/compare/claude-opus-4-7-vs-claude-opus-4-7-adaptive)

## Explore More

- [Apodex 1.1 profile](/models/apodex-1-1)
- [Claude Opus 4.7 (Adaptive) profile](/models/claude-opus-4-7-adaptive)
- [Compare Pricing](/llm-pricing)
- [Alternative Finder](/tools/alternative-finder)
- [LLM Selector](/tools/llm-selector)
- [Overall Rankings](/best/overall)